Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
No matches found
Show only United States results
Show subsections
IND
USA
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
GENMAB - ADR
Genmab - ADR
XNAS: GMAB
Strong Performer, Getting Expensive
Download real time
32.63
-0.72
(
-2.16
%)
89.27% Gain from 52W Low
1.4M
XNAS Volume
XNAS
30 Jan, 2026 4:30 PM (EST)
Watchlist
Portfolio
Alert
My Notes
Board Meeting
The next board meeting for Genmab (ADR) is on 05 Feb 2026 for the purpose of Genmab AS Annual Report for 2025
See details
Overview
Buy Sell Zone
Financials
Forecaster
Competitors/Peers
Quarterly Results
Annual Results
Balance Sheet
Financial Ratios
Cash Flow
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Genmab (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents